Follow
Sushama Talegaonkar
Sushama Talegaonkar
Delhi Pharmaceutical Sciences and Research University, New Delhi
Verified email at dpsru.edu.in
Title
Cited by
Cited by
Year
Development and bioavailability assessment of ramipril nanoemulsion formulation
S Shafiq, F Shakeel, S Talegaonkar, FJ Ahmad, RK Khar, M Ali
European journal of pharmaceutics and biopharmaceutics 66 (2), 227-243, 2007
10012007
Chitosan–sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: Formulation, optimisation and in vitro characterisation
SK Motwani, S Chopra, S Talegaonkar, K Kohli, FJ Ahmad, RK Khar
European Journal of Pharmaceutics and Biopharmaceutics 68 (3), 513-525, 2008
7262008
Zinc oxide nanoparticles: a promising nanomaterial for biomedical applications
PK Mishra, H Mishra, A Ekielski, S Talegaonkar, B Vaidya
Drug discovery today 22 (12), 1825-1834, 2017
7052017
Nanoemulsion components screening and selection: a technical note
A Azeem, M Rizwan, FJ Ahmad, Z Iqbal, RK Khar, M Aqil, S Talegaonkar
Aaps Pharmscitech 10, 69-76, 2009
6022009
Microemulsions: a novel approach to enhanced drug delivery
S Talegaonkar, A Azeem, FJ Ahmad, RK Khar, SA Pathan, ZI Khan
Recent patents on drug delivery & formulation 2 (3), 238-257, 2008
4422008
Formulation development and optimization using nanoemulsion technique: a technical note
S Shafiq-un-Nabi, F Shakeel, S Talegaonkar, J Ali, S Baboota, A Ahuja, ...
AAPS pharmscitech 8, E12-E17, 2007
4192007
Vesicular systems: an overview
S Biju, S Talegaonkar, P Mishra, R Khar
Indian journal of pharmaceutical sciences 68 (2), 2006
4102006
Ceramic nanoparticles: fabrication methods and applications in drug delivery
S C Thomas, P Kumar Mishra, S Talegaonkar
Current pharmaceutical design 21 (42), 6165-6188, 2015
3312015
Emerging significance of flavonoids as P-glycoprotein inhibitors in cancer chemotherapy
T Bansal, M Jaggi, R Khar, S Talegaonkar
Journal of pharmacy & pharmaceutical sciences 12 (1), 46-78, 2009
3092009
Recent approaches for the treatment of periodontitis
N Jain, GK Jain, S Javed, Z Iqbal, S Talegaonkar, FJ Ahmad, RK Khar
Drug discovery today 13 (21-22), 932-943, 2008
3062008
Metal nanoparticles: a theranostic nanotool against cancer
H Sharma, PK Mishra, S Talegaonkar, B Vaidya
Drug discovery today 20 (9), 1143-1151, 2015
3022015
Intranasal delivery: An approach to bypass the blood brain barrier
S Talegaonkar, PR Mishra
Indian journal of pharmacology 36 (3), 140-147, 2004
2792004
CNS drug delivery systems: novel approaches
SA Pathan, Z Iqbal, S Zaidi, S Talegaonkar, D Vohra, GK Jain, A Azeem, ...
Recent patents on drug delivery & formulation 3 (1), 71-89, 2009
2312009
Multiple emulsions: an overview
A Yaqoob Khan, S Talegaonkar, Z Iqbal, F Jalees Ahmed, R Krishan Khar
Current drug delivery 3 (4), 429-443, 2006
2272006
Microemulsions as a surrogate carrier for dermal drug delivery
A Azeem, ZI Khan, M Aqil, FJ Ahmad, RK Khar, S Talegaonkar
Drug development and industrial pharmacy 35 (5), 525-547, 2009
2122009
Novel formulation approaches for optimising delivery of anticancer drugs based on P-glycoprotein modulation
T Bansal, N Akhtar, M Jaggi, RK Khar, S Talegaonkar
Drug discovery today 14 (21-22), 1067-1074, 2009
1942009
Niosomes in sustained and targeted drug delivery: some recent advances
A Azeem, MK Anwer, S Talegaonkar
Journal of drug targeting 17 (9), 671-689, 2009
1782009
Melanoma treatment: from conventional to nanotechnology
H Mishra, PK Mishra, A Ekielski, M Jaggi, Z Iqbal, S Talegaonkar
Journal of cancer research and clinical oncology 144, 2283-2302, 2018
1702018
Advances and potential applications of chitosan derivatives as mucoadhesive biomaterials in modern drug delivery
S Chopra, S Mahdi, J Kaur, Z Iqbal, S Talegaonkar, FJ Ahmad
Journal of Pharmacy and Pharmacology 58 (8), 1021-1032, 2006
1702006
Cellulose nanofiber aerogel as a promising biomaterial for customized oral drug delivery
J Bhandari, H Mishra, PK Mishra, R Wimmer, FJ Ahmad, S Talegaonkar
International journal of nanomedicine, 2021-2031, 2017
1682017
The system can't perform the operation now. Try again later.
Articles 1–20